Mackenzie Colin F, Morrison Chet, Jaberi Mahmood, Genuit Thomas, Katamuluwa Subishani, Rodriguez Aurelio
National Study Center for Trauma and Emergency Medical Systems, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
J Clin Anesth. 2008 Nov;20(7):538-41. doi: 10.1016/j.jclinane.2008.05.012. Epub 2008 Nov 18.
To describe an alternative approach to management of severe life- threatening hemorrhagic shock and the outcome when blood was not a treatment option.
Case Report of the use of a Hemoglobin Based Oxygen Carrier (HBOC-201)when control of hemorrhage and intravenous crystalloids were unsuccessful in reversal of hemorrhagic shock and progressive ischemia.
Trauma Center.
Jehovah's Witness.
Hospital discharge and 6 month follow-up uneventful.
描述一种治疗严重危及生命的出血性休克的替代方法,以及在无法使用血液进行治疗时的治疗结果。
病例报告,当控制出血和静脉输注晶体液无法逆转出血性休克和进行性缺血时,使用基于血红蛋白的氧载体(HBOC-201)。
创伤中心。
耶和华见证人。
出院,6个月随访无异常。